![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 23, 2017 9:53:29 AM
As a biology teacher, I taught the story of the discovery and development of antibiotics, starting, of course, with Fleming’s discovery of the mold Penicillium notatum’s ability to suppress Staphylococcus bacterial cultures on nutrient agar plates. (The species is now known as P. chrysogenum.) This discovery was by propitious happenstance. It occurred because inoculated culture plates had remained un-cleaned for a period, while Fleming was off or doing other things.
Wonderfully, he happened to note Staphylococcus-free zones around the Penicillium growths. Penicillium is a genus of rather common molds. Penicillium spores commonly circulate in the air and drop onto nutrient agar plates, contaminating them. This contamination lead, eventually, to the saving of hundreds of millions of lives — including my mother, a nursing student in WWII. She acquired a bacterial infection that quickly became very serious. The hospital she was being trained at had just received its first shipment of the new penicillin. She was the first there to be given an injected dose, and within a few days of treatment, she was cured. I would never have been without that event (before my birth).
But, as the referenced story states, it was a long and convoluted time and process before penicillin came to the market—for reasons innate to the sociology of modern medicine, and which are still at play with Anavex.
Fleming made his overt, physical discovery of the antibiotic effects of Penicillium chrysogenum in September of 1928. Penicillin didn’t come to practical use until 1942, a 14-year time-to-market period.
Not long after his discovery, Fleming presented a paper, telling of his observations. The professional bacteriology community paid no attention; a mere curiosity of contamination by stray mold spores.
He went on to extract penicillin molecules from the mold, and use them to suppress bacterial infections in mice. He either failed to adequately present this new information to the biology profession, or, they simply paid no attention. Penicillin went virtually un-noticed for a decade. Commercial production didn’t occur until 1941, after intense lab work here in the US, prompted by the onset of WWII. Infected battle wounds are major causes of wartime lethality. Allied use of penicillin was a not-small factor in the war effort.
How does this apply to Anavex’s sigma-1 receptor agonists? We hope, not so much; that a) the molecules would be quickly and accurately recognized as revolutionary medical game-changers (even more so, I contend, than antibiotics in the last century), and b) clinical treatment applications will be forthcoming, treating a diversity of human (and animal?) diseases as soon as possible, without any 14-year lead time.
With the final appearance and availability of penicillin, it quickly came into use. Understandably. Those untreated simply died in a week or so.
But such was not the acceptance of the germ theory itself. Semmelweiss, Pasteur, Lister, et al. showed conclusively that bacteria, “germs,” cause infections. But it took almost a half century for conventional medical science to fully accept the germ theory. Disease was “known” to be caused by bad and re-breathed air, not microscopic organisms in air and water.
In short, medical people have never been quick to re-think what they know and believe about the etiology and treatment of diseases. They know and believe mostly what the medical ancients wrote, and what their med school professors taught, two groups of the most intelligent and knowledgeable humans in all of history.
So, in our case, a team of scientists come along and say (a bit more forcefully than Fleming) that they’ve found a class of novel (new) molecules that restore health to diseased neurons, by formerly unknown mechanisms of action. Of course, the medical community knows better. Alzheimer’s is caused by amyloid and tau protein waste accumulations, and every one of the many attempts to therapeutically clear those has failed. This new Anavex company, we all know, simply can’t have the answer. The known science is better than that.
In the case of penicillin, it was the exigencies of WWII that finally prompted its commercial development and application. In our case, with Anavex, might it be the ever-expanding populations of us Baby Boomers aging into profuse geriatric CNS disease vulnerability?
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM